Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4166947
Max Phase: Preclinical
Molecular Formula: C59H100N12O13
Molecular Weight: 1185.52
Molecule Type: Small molecule
Associated Items:
ID: ALA4166947
Max Phase: Preclinical
Molecular Formula: C59H100N12O13
Molecular Weight: 1185.52
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)(C)C)C(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)N[C@H](C(N)=O)C(C)C)[C@@H](C)O
Standard InChI: InChI=1S/C59H100N12O13/c1-31(2)26-41(63-37(11)73)52(78)62-35(9)50(76)65-42(27-32(3)4)53(79)64-40(18-15-16-24-60)51(77)67-44(29-38-20-22-39(74)23-21-38)55(81)66-43(28-33(5)6)54(80)68-45(30-59(12,13)14)56(82)70-48(36(10)72)58(84)71-25-17-19-46(71)57(83)69-47(34(7)8)49(61)75/h20-23,31-36,40-48,72,74H,15-19,24-30,60H2,1-14H3,(H2,61,75)(H,62,78)(H,63,73)(H,64,79)(H,65,76)(H,66,81)(H,67,77)(H,68,80)(H,69,83)(H,70,82)/t35-,36+,40-,41-,42-,43-,44-,45-,46-,47-,48-/m0/s1
Standard InChI Key: ATYSGHVNNIPMHL-AXRSMUBWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1185.52 | Molecular Weight (Monoisotopic): 1184.7533 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Chen X, Liu L, Chen Y, Yang Y, Yang CY, Guo T, Lei M, Sun H, Wang S.. (2018) Cyclic Peptidic Mimetics of Apollo Peptides Targeting Telomeric Repeat Binding Factor 2 (TRF2) and Apollo Interaction., 9 (5): [PMID:29795768] [10.1021/acsmedchemlett.8b00152] |
Source(1):